Ocera Therapeutics, Inc.: key financial figures for fiscal year 2016 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2016)
- $609.0K
- Net Income/Loss (FY2016)
- -$26.9M
- Total Assets (FY2016)
- $29.6M
- Total Equity (FY2016)
- $15.7M
- Cash Flows from Operating Activities (FY2016)
- -$22.1M
Source: Ocera Therapeutics, Inc. 10-K filing (FY2016). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
